ヒトマイクロバイオームの世界市場（2022年～2030年）：市場シェア、規模、動向、業界分析、製品別、用途別、疾患別、タイプ別、地域別、セグメント予測

世界のヒトマイクロバイオームの市場規模は、2030年までに12億7,630万米ドルに達すると予想されています。

当レポートでは、世界のヒトマイクロバイオーム市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

• レポートについて
  • 調査目的
  • 市場範囲
  • 前提条件
• 利害関係者

第2章 エグゼクティブサマリー

• 市場のハイライト

第3章 調査手法

• 概要
  • データマイニング
• データ情報源
  • 一次情報源
  • 二次情報源

第4章 世界のヒトマイクロバイオーム市場：洞察

• 業界のスナップショット
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターのファイブフォース分析
  • 供給企業の交渉力（中）
  • 新規参入者の脅威（低）
  • 買い手の交渉力（中）
  • 代替の脅威（中）
  • 既存企業間の競争（高）
• PESTLE分析
• 業界の動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界のヒトマイクロバイオーム市場：用途別

• 主な調査結果
• イントロダクション
  • 用途別の世界市場（2018年～2030年）
• 治療
  • 治療別、地域別
• 診断
  • 診断別、地域別

第6章 世界のヒトマイクロバイオーム市場：製品別

• 主な調査結果
• イントロダクション
  • 製品別の世界市場（2018年～2030年）
• プロバイオティクス
  • プロバイオティクス別、地域別
• プレバイオティクス
  • プレバイオティクス別、地域別
• 医療食
  • 医療食別、地域別
• 栄養補助食品
  • 栄養補助食品別、地域別
• その他
  • その他別、地域別

第7章 世界のヒトマイクロバイオーム市場：タイプ別

• 主な調査結果
• イントロダクション
  • タイプ別の世界市場（2018年～2030年）
• FMT
  • FMT別、地域別
• ペプチド
  • ペプチド別、地域別
• 生きた生物学的製剤（LBPs）
  • 生きた生物学的製剤（LBPs）別、地域別
• その他
  • その他別、地域別

第8章 世界のヒトマイクロバイオーム市場：疾患別

• 主な調査結果
• イントロダクション
  • 疾患別の世界市場（2018年～2030年）
• 感染症
  • 感染症別、地域別
• 内分泌疾患
  • 内分泌疾患別、地域別
• 代謝疾患
  • 代謝疾患別、地域別

第9章 世界のヒトマイクロバイオーム市場：地域別

• 主な調査結果
• イントロダクション
  • ヒトマイクロバイオーム市場の評価：地域別（2018年～2030年）
• 北米
  • 用途別
  • 疾患別
  • 製品別
  • タイプ別
  • 米国
  • カナダ
• 欧州
  • 用途別
  • 疾患別
  • 製品別
  • タイプ別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
• アジア太平洋地域
  • 用途別
  • 疾患別
  • 製品別
  • タイプ別
  • 中国
  • インド
  • 日本
  • マレーシア
  • インドネシア
  • 韓国
• 中東・アフリカ
  • 用途別
  • 疾患別
  • 製品別
  • タイプ別
  • サウジアラビア
  • 南アフリカ
  • イスラエル
  • アラブ首長国連邦
• ラテンアメリカ
  • 用途別
  • 疾患別
  • 製品別
  • タイプ別
  • メキシコ
  • ブラジル
  • アルゼンチン

第10章 競合情勢

• 拡張と買収の分析
  • 拡張
  • 買収
• パートナーシップ/コラボレーション/協定/展示会

第11章 企業プロファイル

• Rebiotix
• Metabiomics Corporate
• Yakult Honsha
• Osel Inc
• Vedanta Biosciences, Inc
• Synthetic Biologics
• DuPont

List of Tables

• Table 1 Global Human Microbiome Market, by Application, by Region, 2018 - 2030 (USD Million)
• Table 2 Global Human Microbiome Market, by Product, by Region, 2018 - 2030 (USD Million)
• Table 3 Global Human Microbiome Market, by Type, by Region, 2018 - 2030 (USD Million)
• Table 4 Global Human Microbiome Market, by Disease, by Region, 2018 - 2030 (USD Million)
• Table 5 Human Microbiome Market Assessment, By Geography, 2018 - 2030 (USD Million)
• Table 6 North America: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 7 North America: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 8 North America: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 9 North America: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 10 U.S.: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 11 U.S.: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 12 U.S.: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 13 U.S.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 14 Canada: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 15 Canada: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 16 Canada: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 17 Canada: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 18 Europe: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 19 Europe: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 20 Europe: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 21 Europe: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 22 Germany: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 23 Germany: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 24 Germany: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 25 Germany: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 26 France: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 27 France: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 28 France: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 29 France: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 30 UK: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 31 UK: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 32 UK: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 33 UK: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 34 Italy: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 35 Italy: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 36 Italy: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 37 Italy: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 38 Netherlands: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 39 Netherlands: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 40 Netherlands: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 41 Netherlands: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 42 Spain: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 43 Spain: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 44 Spain: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 45 Spain: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 46 Russia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 47 Russia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 48 Russia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 49 Russia: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 54 China: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 55 China: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 56 China: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 57 China: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 58 Japan: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 59 Japan: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 60 Japan: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 61 Japan: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 62 India: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 63 India: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 64 India: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 65 India: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 66 Indonesia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 67 Indonesia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 68 Indonesia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 69 Indonesia: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 70 Malaysia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 71 Malaysia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 72 Malaysia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 73 Malaysia: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 74 South Korea: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 75 South Korea: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 76 South Korea: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 77 South Korea: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 78 Latin America: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 79 Latin America: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 80 Latin America: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 81 Latin America: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 82 Brazil: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 83 Brazil: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 84 Brazil: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 85 Brazil: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 86 Mexico: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 87 Mexico: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 88 Mexico: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 89 Mexico: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 90 Argentina: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 91 Argentina: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 92 Argentina: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 93 Argentina: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 94 Middle East & Africa: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 95 Middle East & Africa: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 96 Middle East & Africa: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 97 Middle East & Africa: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 98 UAE: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 99 UAE: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 100 UAE: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 101 UAE: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 102 Saudi Arabia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 103 Saudi Arabia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 104 Saudi Arabia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 105 Saudi Arabia: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 106 South Africa: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 107 South Africa: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 108 South Africa: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 109 South Africa: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• Table 110 Israel: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• Table 111 Israel: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• Table 112 Israel: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• Table 113 Israel: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)

List of Figures

Figure 1. Global Human Microbiome Market, 2018 - 2030 (USD Million)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Disease

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Application

Figure 7. Global Human Microbiome Market, by Application, 2021 & 2030 (USD Million)

Figure 8. Market by Disease

Figure 9. Global Human Microbiome Market, by Disease, 2021 & 2030 (USD Million)

Figure 10. Market by Product

Figure 11. Global Human Microbiome Market, by Product, 2021 & 2030 (USD Million)

Figure 12. Market by Type

Figure 13. Global Human Microbiome Market, by Type, 2021 & 2030 (USD Million)

Figure 14. Human Microbiome Market Assessment, By Geography, 2018 - 2030 (USD Million)

Figure 15. Strategic Analysis - Human Microbiome Market

The global human microbiome market size is expected to reach USD 1,276.3 million by 2030, according to a new study by Polaris Market Research. The report "Human Microbiome Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, Supplements, and Others); By Application; By Disease, By Type; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

With so many small high-tech firms functioning in the industry, there are numerous high-growth prospects for important stakeholders to purchase out corporations in order to investigate microbiomes with the goal of uncovering novel medications and therapeutic targets for various indications such as obesity, diabetes, liver problems, and metabolic diseases. Many industry leaders are working on strategic alliances and partnerships to expand their product pipelines through well-organized R&D approaches.

Several alliances and partnerships involving large corporations have occurred in the recent two years. The FDA has not authorized any probiotics as a live biotechnology-derived product. However, there are U.S. food and drug administration foods, including nutritional supplements, incorporating microorganisms that are legitimately accessible. Still, these items cannot be legally advertised to reduce or avoid illness.

The federal government's increased investment is expected to support market expansion. Furthermore, the high return on investment ensured by research efforts would benefit the industry. Contrarily, high costs associated with R&D capabilities, limited infrastructure, and insufficient research on the human microbiome are projected to stymie market expansion. In addition, a lack of favorable economic scenarios and technological penetration in emerging economies, obstacles to proving the causal connection between dysbiosis and illnesses, and a lack of suitable infrastructure in low & middle-income countries are expected to pose challenges to the market for the foreseeable future.

Human Microbiome Market Report Highlights

North America will be the dominating region in the global market in 2021. The region's dominance is attributed to factors such as the presence of well-established players and advancements in the R&D toward gut microbiome.

By application, the therapeutics segment dominated the global market owing to increased funding for R&D into microbiome-based therapies across developing nations such as India and developed nations such as the US.

By disease, infectious diseases account for the largest share owing to weak immune systems and less availability of nutritional diets across developing countries such as Africa, China, and India.

By Product, the probiotic segment is the largest and fastest-growing segment owing to growing awareness among consumers for healthy and natural foods. Furthermore, the pandemic had a favorable impact on sales in this segment.

Key players in the global market include Rebiotix., Metabiomics, Yakult Honsha, Osel Inc., Vedanta Biosciences, Synthetic Biologics, and DuPont.

Polaris Market Research has segmented the human microbiome market report based on type, application, disease, product, and region:

Human Microbiome, Product Outlook (Revenue - USD Million, 2018 - 2030)

Probiotics

Prebiotics

Medical Foods

Supplements

Others

Human Microbiome, Disease Outlook (Revenue - USD Million, 2018 - 2030)

Infectious

Endocrine

Metabolic

Human Microbiome, Application Outlook (Revenue - USD Million, 2018 - 2030)

Therapeutics

Diagnostics

Human Microbiome, Type Outlook (Revenue - USD Million, 2018 - 2030)

FMT

Peptide

Live Biotherapeutic Product

Others

Human Microbiome, Regional Outlook (Revenue - USD Million, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Human Microbiome Market Insights

• 4.1. Human Microbiome - Industry Snapshot
• 4.2. Human Microbiome Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing collaboration between public-private organizations
    • 4.2.1.2. Growing research activity in medical drug discovery
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Government regulations
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. Human Microbiome Industry Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Human Microbiome Market, by Application

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
• 5.3. Therapeutics
  • 5.3.1. Global Human Microbiome Market, by Therapeutics, by Region, 2018 - 2030 (USD Million)
• 5.4. Diagnostics
  • 5.4.1. Global Human Microbiome Market, by Diagnostics, by Region, 2018 - 2030 (USD Million)

6. Global Human Microbiome Market, by Product

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
• 6.3. Probiotics
  • 6.3.1. Global Human Microbiome Market, by Probiotics, by Region, 2018 - 2030 (USD Million)
• 6.4. Prebiotics
  • 6.4.1. Global Human Microbiome Market, by Prebiotics, by Region, 2018 - 2030 (USD Million)
• 6.5. Medical Foods
  • 6.5.1. Global Human Microbiome Market, by Medical Foods, by Region, 2018 - 2030 (USD Million)
• 6.6. Supplements
  • 6.6.1. Global Human Microbiome Market, by Supplements, by Region, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Global Human Microbiome Market, by Others, by Region, 2018 - 2030 (USD Million)

7. Global Human Microbiome Market, by Type

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• 7.3. FMT
  • 7.3.1. Global Human Microbiome Market, by FMT, by Region, 2018 - 2030 (USD Million)
• 7.4. Peptide
  • 7.4.1. Global Human Microbiome Market, by Peptide, by Region, 2018 - 2030 (USD Million)
• 7.5. Live Biotherapeutic Product
  • 7.5.1. Global Human Microbiome Market, by Live Biotherapeutic Product, by Region, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Global Other Human Microbiome Market, by Region, 2018 - 2030 (USD Million)

8. Global Human Microbiome Market, by Disease

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
• 8.3. Infectious
  • 8.3.1. Global Human Microbiome Market, by Infectious, by Region, 2018 - 2030 (USD Million)
• 8.4. Endocrine
  • 8.4.1. Global Human Microbiome Market, by Endocrine, by Region, 2018 - 2030 (USD Million)
• 8.5. Metabolic
  • 8.5.1. Global Human Microbiome Market, by Metabolic, by Region, 2018 - 2030 (USD Million)

9. Global Human Microbiome Market, by Geography

• 9.1. Key findings
• 9.2. Introduction
  • 9.2.1. Human Microbiome Market Assessment, By Geography, 2018 - 2030 (USD Million)
• 9.3. Human Microbiome Market - North America
  • 9.3.1. North America: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
  • 9.3.2. North America: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
  • 9.3.3. North America: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
  • 9.3.4. North America: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.3.5. Human Microbiome Market - U.S.
    • 9.3.5.1. U.S.: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.3.5.2. U.S.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.3.5.3. U.S.: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.3.5.4. U.S.: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.3.6. Human Microbiome Market - Canada
    • 9.3.6.1. Canada: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.3.6.2. Canada: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.3.6.3. Canada: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.3.6.4. Canada: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• 9.4. Human Microbiome Market - Europe
  • 9.4.1. Europe: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
  • 9.4.2. Europe: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
  • 9.4.3. Europe: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
  • 9.4.4. Europe: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.4.5. Human Microbiome Market - UK
    • 9.4.5.1. UK: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.4.5.2. UK: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.4.5.3. UK: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.4.5.4. UK: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.4.6. Human Microbiome Market - France
    • 9.4.6.1. France: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.4.6.2. France: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.4.6.3. France: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.4.6.4. France: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.4.7. Human Microbiome Market - Germany
    • 9.4.7.1. Germany: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.4.7.2. Germany: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.4.7.3. Germany: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.4.7.4. Germany: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.4.8. Human Microbiome Market - Italy
    • 9.4.8.1. Italy: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.4.8.2. Italy: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.4.8.3. Italy: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.4.8.4. Italy: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.4.9. Human Microbiome Market - Spain
    • 9.4.9.1. Spain: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.4.9.2. Spain: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.4.9.3. Spain: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.4.9.4. Spain: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.4.10. Human Microbiome Market - Netherlands
    • 9.4.10.1. Netherlands: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.4.10.2. Netherlands: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.4.10.3. Netherlands: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.4.10.4. Netherlands: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.4.11. Human Microbiome Market - Russia
    • 9.4.11.1. Russia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.4.11.2. Russia.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.4.11.3. Russia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.4.11.4. Russia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• 9.5. Human Microbiome Market - Asia Pacific
  • 9.5.1. Asia Pacific: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
  • 9.5.2. Asia Pacific: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
  • 9.5.3. Asia Pacific: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
  • 9.5.4. Asia Pacific: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.5.5. Human Microbiome Market - China
    • 9.5.5.1. China: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.5.5.2. China.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.5.5.3. China: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.5.5.4. China: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.5.6. Human Microbiome Market - India
    • 9.5.6.1. India: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.5.6.2. India.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.5.6.3. India: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.5.6.4. India: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.5.7. Human Microbiome Market - Japan
    • 9.5.7.1. Japan: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.5.7.2. Japan.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.5.7.3. Japan: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.5.7.4. Japan: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.5.8. Human Microbiome Market - Malaysia
    • 9.5.8.1. Malaysia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.5.8.2. Malaysia.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.5.8.3. Malaysia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.5.8.4. Malaysia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.5.9. Human Microbiome Market - Indonesia
    • 9.5.9.1. Indonesia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.5.9.2. Indonesia.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.5.9.3. Indonesia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.5.9.4. Indonesia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.5.10. Human Microbiome Market - South Korea
    • 9.5.10.1. South Korea: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.5.10.2. South Korea.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.5.10.3. South Korea: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.5.10.4. South Korea: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• 9.6. Human Microbiome Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
  • 9.6.2. Middle East & Africa: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
  • 9.6.3. Middle East & Africa: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
  • 9.6.4. Middle East & Africa: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.6.5. Human Microbiome Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.6.5.2. Saudi Arabia: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.6.5.3. Saudi Arabia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.6.5.4. Saudi Arabia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.6.6. Human Microbiome Market - South Africa
    • 9.6.6.1. South Africa: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.6.6.2. South Africa: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.6.6.3. South Africa: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.6.6.4. South Africa: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.6.7. Human Microbiome Market - Israel
    • 9.6.7.1. Israel: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.6.7.2. Israel: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.6.7.3. Israel: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.6.7.4. Israel: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.6.8. Human Microbiome Market - UAE
    • 9.6.8.1. UAE: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.6.8.2. UAE: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.6.8.3. UAE: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.6.8.4. UAE: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
• 9.7. Human Microbiome Market - Latin America
  • 9.7.1. Latin America: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
  • 9.7.2. Latin America: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
  • 9.7.3. Latin America: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
  • 9.7.4. Latin America: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.7.5. Human Microbiome Market - Mexico
    • 9.7.5.1. Mexico: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.7.5.2. Mexico: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.7.5.3. Mexico: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.7.5.4. Mexico: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.7.6. Human Microbiome Market - Brazil
    • 9.7.6.1. Brazil: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.7.6.2. Brazil: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.7.6.3. Brazil: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.7.6.4. Brazil: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
  • 9.7.7. Human Microbiome Market - Argentina
    • 9.7.7.1. Argentina: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
    • 9.7.7.2. Argentina: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
    • 9.7.7.3. Argentina: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
    • 9.7.7.4. Argentina: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Rebiotix
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Metabiomics Corporate
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Yakult Honsha
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Osel Inc
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Vedanta Biosciences, Inc
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Synthetic Biologics
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. DuPont
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development